Janney Montgomery Scott
TOVX icon

Janney Montgomery Scott’s Theriva Biologics TOVX Stock Holding History

Janney Montgomery Scott’s Portfolio TOVX Stock Details TOVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-2
Closed -$13K – 1803
2016
Q4 		$13K Buy
+2
New +$20.5K ﹤0.01% 1673
2015
Q3 		– Sell
-21
Closed -$531K – 1465
2015
Q2 		$531K Buy
21
+19
+950% +$381K 0.01% 1141
2015
Q1 		$42K Buy
+2
New +$35.7K ﹤0.01% 2355
2014
Q4 		– Sell
-17
Closed -$265K – 2389
2014
Q3 		$265K Sell
17
-1
-6% -$16.3K 0.01% 1758
2014
Q2 		$269K Sell
18
-13
-42% -$206K 0.01% 1701
2014
Q1 		$688K Hold
31
– – 0.02% 934
2013
Q4 		$410K Sell
31
-4
-11% -$50.5K 0.01% 1218
2013
Q3 		$508K Buy
+35
New +$481K 0.02% 981

Other funds holding TOVX

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janney Montgomery Scott's TOVX Position: Q1 2017 in Review

Janney Montgomery Scott sold out of Theriva Biologics (TOVX) in Q1 2017, closing a stake of 2 shares — an estimated $13K sold.

Janney Montgomery Scott first reported a position in TOVX in Q3 2013 and held it in 8 quarters. The position peaked at $688K in Q1 2014. 74 funds tracked by Wall St. Rank hold TOVX as of Q1 2017.

  • Janney Montgomery Scott reported no remaining Theriva Biologics position as of Q1 2017 after selling out during the quarter.
  • Janney Montgomery Scott sold 2 Theriva Biologics shares in Q1 2017, an estimated $13K.
  • Janney Montgomery Scott first reported a position in Theriva Biologics in Q3 2013 and held it in 8 quarters.
  • Janney Montgomery Scott's Theriva Biologics position peaked at $688K in Q1 2014.
  • 74 funds tracked by Wall St. Rank held Theriva Biologics as of Q1 2017.

Based on Janney Montgomery Scott's 13F filing for Q1 2017, filed 26 Apr 2017.